Taxotere, a cancer drug used in chemotherapy, may cause permanent hair loss or alopecia. The manufacturer of Taxotere (docetaxel) Sanofi-Aventis confronts Taxotere suits for failing to warn physicians and sufferers of the irreversible “side effect” Taxotere Lawsuit. You can browse www.taxoterehairlawsuit.com/taxotere-hair-loss-lawsuit.aspx to know more about Taxotere.
Permanent Hair Reduction Lawsuits over Taxotere say that its manufacturer Sanofi-Aventis neglected to warn patients and physicians that Taxotere raises the danger of alopecia, permanent baldness.
Alopecia Due to Taxotere Sanofi Aventis started to warn U.S. sufferers of the probability of permanent alopecia just after being ordered to do this by that the FDA in December 2015. Patients in Europe and Canada, meanwhile, were cautioned about permanent baldness from Taxotere back in 2005.
U.S. physicians and patients were oblivious to Taxotere’s threat of alopecia. They’re unaware of an alternate chemotherapy drug that’s only as successful, as it comes without Taxotere’s permanent unwanted effects.Chemotherapy Hair Loss vs. Taxotere AlopeciaBaldness in chemotherapy is a famous side impact, but the hair is anticipated to grow back over 3-6 weeks of stopping chemo. Approximately 10-15% of girls that used Taxotere throughout chemo reported no hair development for as long as ten years later quitting “treatment”
Types of Alopecia / Permanent Hair Reduction Alopecia can come in many unique forms, such as:
- Total baldness of body and scalp
- Lack of lashes
- Lack of eyebrows
- Non-existent hair development underarms or around genitals.